Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

U.S. judge says may order halt to integration of CVS-Aetna

Published 03/12/2018, 19:20
© Reuters. FILE PHOTO: Shoppers walk outside a CVS store and pharmacy in Medford

By Diane Bartz

WASHINGTON (Reuters) - A federal judge who has been asked to sign off on the government's decision to approve CVS Health Corp's (N:CVS) acquisition of insurer Aetna Inc (NYSE:AET) indicated on Monday he may ask the companies to halt integration pending his decision.

Judge Richard Leon of the U.S. District Court for the District of Columbia complained at a hearing last week that the two sides had treated him as a "rubber stamp" for the deal. CVS closed the $69 billion transaction last week and began the integration process.

Leon said at a hearing on Monday that he would issue an order asking the two sides to argue why he should not require CVS and Aetna to be held separate until he decides whether he will approve the consent agreement reached in October between the companies and the U.S. Justice Department.

Makan Delrahim, the assistant attorney general for antitrust, declined comment after the hearing.

A CVS spokesman said in an email after the hearing: "CVS Health and Aetna are one company, and our focus is on transforming the consumer health experience."

Leon said during the brief hearing that he was "concerned" the Justice Department's filing with the court pointed to antitrust issues. In October, the Justice Department approved the merger of CVS, a pharmacy chain and benefits manager, and Aetna on condition that the health insurer sell its Medicare Part D drug plan business to WellCare Health Plans Inc (N:WCG).

Most deals struck between the government and companies to resolve antitrust concerns are approved by federal courts with little fuss under the 1974 Tunney Act, which requires courts to ensure the agreement is in the public interest.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Companies generally do not wait for final court approval before closing their transactions.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.